GVA:NYSEGranite Construction Incorporated Analysis
Data as of 2026-06-13 - not real-time
$140.60
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The 20‑day SMA sits comfortably above both the 50‑day and 200‑day SMAs, confirming a bullish trend, while the RSI is in the mid‑50s, suggesting momentum remains intact. The MACD histogram has turned slightly negative, hinting at emerging bearish pressure as the price approaches the identified resistance around $144. Volume has been tapering, beta hovers near 1.0 and 30‑day volatility is elevated at roughly 27%, all set against an "Extreme Greed" market sentiment.
Fundamental backdrop: Granite posted a 30% YoY revenue surge and smashed Q1 expectations, prompting an upward revision of its 2026 guidance and a surge in its backlog. However, operating margins remain negative, debt‑to‑equity exceeds 120%, and the dividend yield is modest at 0.37% with a low payout ratio. A DCF‑derived fair value near $85 versus the current $140 price flags a pronounced overvaluation, while the recent $600 M senior‑note offering adds leverage concerns despite the cash‑rich balance sheet.
Fundamental backdrop: Granite posted a 30% YoY revenue surge and smashed Q1 expectations, prompting an upward revision of its 2026 guidance and a surge in its backlog. However, operating margins remain negative, debt‑to‑equity exceeds 120%, and the dividend yield is modest at 0.37% with a low payout ratio. A DCF‑derived fair value near $85 versus the current $140 price flags a pronounced overvaluation, while the recent $600 M senior‑note offering adds leverage concerns despite the cash‑rich balance sheet.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Bullish moving‑average alignment
- Q1 earnings beat and raised guidance
- Momentum reflected in RSI and market sentiment
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong revenue growth but negative operating margin
- High leverage from recent note issuance
- Price already near 52‑week high with limited upside
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Potential tail‑off of infrastructure stimulus after 2026
- Elevated debt‑to‑equity and overvaluation relative to DCF
- Operating margin pressure and modest dividend yield
Key Metrics & Analysis
Financial Health
Revenue Growth30.40%
Profit Margin3.99%
P/E Ratio38.3
ROE20.03%
ROA5.24%
Debt/Equity129.13
P/B Ratio6.0
Op. Cash Flow$434.4M
Free Cash Flow$129.4M
Industry P/E30.6
Technical Analysis
TrendBullish
RSI58.0
Support$126.28
Resistance$144.11
MA 20$136.47
MA 50$132.74
MA 200$119.29
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$85.33
Target Price$167.20
Upside/Downside18.92%
GradeOvervalued
TypeGrowth
Dividend Yield0.37%
Risk Assessment
Beta1.02
Volatility27.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.